Radiation Therapy for Breast Cancer: Current Status and Future Perspectives

Dear Colleagues,

Breast cancer represents the malignancy most widely treated by radiation oncologists.  As a result, it has been the subject of numerous studies and practices have evolved over time. An array of creative questions has been posed within the field of breast radiation oncology with the goals of improving cancer outcomes, decreasing treatment related toxicity, and improving quality of life for breast cancer patients and survivors.

In this Special Issue of Current Oncology, we welcome the input from leaders in the field of radiation. Contributors may wish to explore one of the topics identified by the editors (e.g., radiation dose de-escalation, boost techniques, partial breast irradiation, re-irradiation, nodal management, onco-plastics, the treatment of oligometastatic and oligoprogressive disease, incorporating bio-signatures into radiotherapeutic management, testing the limits of hypofractionation, addressing disparities in breast RT, new technologies such as proton and MR guidance, etc.) or propose alternative concepts which they deem valuable. In so doing, we hope to produce a volume which is scholarly, thought-provoking, and clinically relevant.

Dr. Benjamin W. Corn
Dr. Shira L. Galper
Prof. Dr. Merav A. Ben-David
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.